Male Infertility Market is expected to grow with a CAGR of x.x% during the forecast period of 2018 to 2025.
Infertility is diagnosed when a couple who is unable to conceive, trying over the course of one year. When the problem lies with the male partner it is referred to as male infertility. Infertility is a widespread problem. A man’s fertility generally relies on the quantity and quality of his sperm. If the number of sperm a man ejaculates is low or if the sperm is of a poor quality, it will be difficult, and sometimes impossible, for him to cause pregnancy. For about one in five infertile couples, the problem lies solely in the male partner. It is estimated that approximately 7% of all men are infertile. The basic treatments involved in male infertility are surgery, treatment for problems in intercourse, hormone treatment, and ART technology.
Male Infertility Market Dynamics
Both the developed and developing nations are facing infertility issues as a result of improper lifestyle. Delayed pregnancy and aging are the major factors driving the global infertility cases. Moreover, advancement in the ART technology is a major issue which is pushing the market growth. However, negative impact generated due to repeated failures in treatment and social & cultural taboos can restrain the market growth. On the other hand, increased awareness level may lead to market growth.
Male Infertility Market Segmentation
The segmentation of the male infertility market is done on the basis of techniques, treatment and geography. By techniques, the market is segmented into DNA Fragmentation, Oxidative stress analysis, microscopic examination, sperm penetration assay, sperm agglutination, computer assisted semen analysis and others. By treatment, the market is segmented as assisted reproductive technology and medication. Geographically, the market is bifurcated as North America, Europe, Asia-Pacific and Rest of World.
Key market players of the global male infertility market are EMD Serono, Inc., Cadila Healthcare LtdASKA pharmaceuticals, Inc., Intas pharmaceuticals Ltd., Pantarhei Bioscience B.V., Cordex Pharma, In, Halotech DNA SL, SCSA diagnostics, Inc., Andrology solutions, Access Pharmaceuticals, Inc.
MALE INFERTILITY MARKET SEGMENTATION
Market by techniques
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Penetration Assay
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Assisted Reproductive Technology
Market by geography
• North America
• Asia Pacific
MALE INFERTILITY MARKET PLAYERS
• EMD Serono, Inc.
• Cadila Healthcare Ltd
• ASKA Pharmaceuticals, Inc.
• Intas Pharmaceuticals Ltd.
• Pantarhei Bioscience B.V.
• Cordex Pharma, In
• Halotech DNA SL
• SCSA Diagnostics, Inc.
• Andrology solutions
• Access Pharmaceuticals, Inc.